ACG Clinical Guideline: Management of Crohn's Disease in Adults
- PMID: 29610508
- DOI: 10.1038/ajg.2018.27
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Erratum in
-
Correction: ACG Clinical Guideline: Management of Crohn's Disease in Adults.Am J Gastroenterol. 2018 Jul;113(7):1101. doi: 10.1038/s41395-018-0120-x. Am J Gastroenterol. 2018. PMID: 29895986
Abstract
Crohn's disease is an idiopathic inflammatory disorder of unknown etiology with genetic, immunologic, and environmental influences. The incidence of Crohn's disease has steadily increased over the past several decades. The diagnosis and treatment of patients with Crohn's disease has evolved since the last practice guideline was published. These guidelines represent the official practice recommendations of the American College of Gastroenterology and were developed under the auspices of the Practice Parameters Committee for the management of adult patients with Crohn's disease. These guidelines are established for clinical practice with the intent of suggesting preferable approaches to particular medical problems as established by interpretation and collation of scientifically valid research, derived from extensive review of published literature. When exercising clinical judgment, health-care providers should incorporate this guideline along with patient's needs, desires, and their values in order to fully and appropriately care for patients with Crohn's disease. This guideline is intended to be flexible, not necessarily indicating the only acceptable approach, and should be distinguished from standards of care that are inflexible and rarely violated. To evaluate the level of evidence and strength of recommendations, we used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The Committee reviews guidelines in depth, with participation from experienced clinicians and others in related fields. The final recommendations are based on the data available at the time of the production of the document and may be updated with pertinent scientific developments at a later time.
Comment in
-
Comment on 2018 ACG Clinical Guideline: Antibiotics in Crohn's Disease.Am J Gastroenterol. 2019 Jan;114(1):170-171. doi: 10.1038/s41395-018-0281-7. Am J Gastroenterol. 2019. PMID: 30333546 No abstract available.
-
ACG Clinical Guideline on Crohn's Disease: A Point of View from Europe.Am J Gastroenterol. 2019 May;114(5):826. doi: 10.1038/s41395-018-0410-3. Am J Gastroenterol. 2019. PMID: 30410037 No abstract available.
-
Response to Chamberlin and Borody.Am J Gastroenterol. 2019 Jan;114(1):171-174. doi: 10.14309/ajg.0000000000000077. Am J Gastroenterol. 2019. PMID: 30633034 No abstract available.
-
Underscoring the Biochemical Overlap Between Crohn's Disease and Depression.Am J Gastroenterol. 2019 May;114(5):827-828. doi: 10.14309/ajg.0000000000000063. Am J Gastroenterol. 2019. PMID: 30676365 No abstract available.
-
Response to Ribaldone.Am J Gastroenterol. 2019 May;114(5):826-827. doi: 10.14309/ajg.0000000000000216. Am J Gastroenterol. 2019. PMID: 30985300 No abstract available.
-
Response to Chapman and Jones.Am J Gastroenterol. 2019 May;114(5):828. doi: 10.14309/ajg.0000000000000217. Am J Gastroenterol. 2019. PMID: 30985301 No abstract available.
Similar articles
-
Management of Crohn's disease in adults.Am J Gastroenterol. 1997 Apr;92(4):559-66. Am J Gastroenterol. 1997. PMID: 9128300 Review.
-
Management of Crohn's disease in adults.Am J Gastroenterol. 2009 Feb;104(2):465-83; quiz 464, 484. doi: 10.1038/ajg.2008.168. Epub 2009 Jan 6. Am J Gastroenterol. 2009. PMID: 19174807
-
Use of Anti-Tumor Necrosis Factors and Anti-Integrins in the Treatment of Crohn's Disease.Gastroenterol Clin North Am. 2017 Sep;46(3):589-601. doi: 10.1016/j.gtc.2017.05.012. Gastroenterol Clin North Am. 2017. PMID: 28838417 Review.
-
Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.Am J Gastroenterol. 1997 Jul;92(7):1081-91. Am J Gastroenterol. 1997. PMID: 9219775 Review.
-
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893. doi: 10.1002/14651858.CD006893. Cochrane Database Syst Rev. 2008. PMID: 18254120 Review.
Cited by
-
Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis.BMJ Med. 2024 Oct 28;3(1):e000998. doi: 10.1136/bmjmed-2024-000998. eCollection 2024. BMJ Med. 2024. PMID: 39574425 Free PMC article.
-
Orofacial Granulomatosis and Crohn's Disease: A Case Series.ACG Case Rep J. 2024 Nov 16;11(11):e01559. doi: 10.14309/crj.0000000000001559. eCollection 2024 Nov. ACG Case Rep J. 2024. PMID: 39559789 Free PMC article.
-
Navigating SARS-CoV-2-related immunopathology in Crohn's disease: from molecular mechanisms to therapeutic challenges.Virol J. 2024 Nov 13;21(1):288. doi: 10.1186/s12985-024-02529-1. Virol J. 2024. PMID: 39538233 Free PMC article. Review.
-
Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD.Endosc Int Open. 2024 Nov 11;12(11):E1285-E1294. doi: 10.1055/a-2437-8102. eCollection 2024 Nov. Endosc Int Open. 2024. PMID: 39534278 Free PMC article.
-
The Role of Gut Microbiota in the Efficacy and Side Effect Profile of Biologic Therapies for Autoimmune Diseases.Cureus. 2024 Oct 8;16(10):e71111. doi: 10.7759/cureus.71111. eCollection 2024 Oct. Cureus. 2024. PMID: 39525264 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
